Study: ED-ICU Collaboration Reduced Sepsis Mortality, Costs
"Although ICU level of care is costly, earlier inclusion of borderline patients may improve mortality," says lead researcher Joseph Carrington, MD, Northwest Hospital and Lifebridge Critical Care in Randallstown, Maryland. "It may also significantly decrease resource utilisation, as our study found."
For this study, Dr. Carrington and his colleague, Jaime Barnes, DO, also of Northwest Hospital, reviewed 886 medical records from patients with sepsis admitted to the ICU of a community hospital. There was collaboration between the ED and ICU in admitting traditionally “borderline” patients to the ICU, as well as utilising standardised ICU admission criteria for septic patients.
The researchers compared mortality and length of stay before and after making ICU admission criteria less stringent for patients with sepsis. They found that upon easing of ICU admission criteria, overall mortality decreased by 45.4 percent (from 14.38 percent to 7.85 percent). Although the severity of the illness did not change, ICU length of stay was 25.9 percent lower in the post-implementation cohort (3.97 days vs. 2.94 days). In addition, the number of intermediate care unit patients who were transferred to the ICU also decreased by 67.1 percent (from 3.89 percent to 1.28 percent).
"In addition to improved outcomes, annualised cost savings in our new model were $2,286,600 (based on average cost of $2,500/ICU-day)," the authors write.
The results show that developing a collaborative culture between the ED and ICU and lowering ICU admission thresholds not only provide smarter use of ICUs but may also help improve annual cost savings in hospitals, according to the authors.
Further results will be shared during CHEST Annual Meeting 2015, held in Montréal, Canada on 24-28 October.
Source: American College of Chest Physicians
Image credit: Flickr.com
«« Johns Hopkins Partners with IT Giant on ICU Devices
Sleep in the ICU: Cochrane Review of Non-Drug Interventions »»
Published on : Fri, 23 Oct 2015
StatStrip® and StatStrip Xpress®2 Glucose/Ketone Meters
Not yet available in the U.S. The most extensively studied and proven glucose measurement technology In addition to studies submitted to the FDA, 168 other independent studies over the last eight years—including 53 critical care studies—have...
Transport of ECLS patients
The Xenios MultiSupport GROUND (MSG) is a system consisting of different components, designed to enable inner- and inter-hospital transport of severely ill patients undergoing life-saving extracorporeal heart and lung support. As a whole, the Xenios...
Stat Profile Prime® ES Plus Analyzer
Not available in all markets Exceptional Simplicity in a New Generation Electrolyte Analyzer Introducing a new generation electrolyte analyzer that combines the revolutionary microelectronics of the consumer world with new microsensor...
iLA Membrane Ventilator
The world’s only pumpless extrapulmonary gas exchange system
The iLA membrane ventilator is an extrapulmonary ventilation system which is used to remove carbon dioxide. The heart pumps blood through the iLA membrane ventilator as it does through a natural organ. The iLA membrane ventilator “breathes” outside...
IVD CAPSULE PSP
For Early Sepsis Detection
IVD CAPSULE PSP The IVD CAPSULE PSP is a rapid, single-use in vitro diagnostic test for the quantitative measurement of pancreatic stone protein (PSP) in blood. The test is intended to be used in conjunction with other clinical assessments and laboratory...